FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:1721-1722 April 21, 2005 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Grinspoon, S. PubMed Citation

To the Editor: In their review of metabolic and cardiovascular risk factors affecting patients infected with the human immunodeficiency virus (HIV), Grinspoon and Carr (Jan. 6 issue)¹ recommend the guidelines of the National Cholesterol Education Program for lipid-lowering therapy in HIV-infected patients with hyperlipidemia. Prediction of coronary heart disease (CHD) with the use of the Framingham equation, however, is based on (and principally predictive for) outpatients free of disease.² Estimation of the 10-year risk of CHD at any point is based on the person's past and expected future lipid levels (which are best assessed as the area under the curve, . . . [Full Text of this Article]

This article has been cited by other articles:

• Morales, E., Gutierrez-Solis, E., Gutierrez, E., Gonzalez, R., Martinez, M. A., Praga, M. (2008). Malignant hypertension in HIV-associated glomerulonephritis. Nephrol Dial Transplant 0: gfn407v1-gfn407 [Abstract] [Full Text]